Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Peptide Analgesics – Opioid Peptides
κ-opioid receptor - Wikipedia
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife
Nephrology Journal Club on Twitter: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
Kinase cascades and ligand-directed signaling at the kappa opioid receptor | SpringerLink
Opioids in cancer: The κ‑opioid receptor (Review)
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Opioid Receptors Mnemonic | Epomedicine
Antagonists of the kappa opioid receptor - ScienceDirect
Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Development of κ opioid receptor antagonists. | Semantic Scholar
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
